Orencia (abatacept) - BMS
Effect of abatacept on bone in patients with psoriatic arthritis-results from a prospective interventional high-resolution imaging study (ABEPSA). (PubMed, EULAR Rheumatol Open) - Oct 11, 2026 - "ABA prevented new erosions and structural entheseal lesions over 24 weeks, indicating a potential osteoprotective effect. These results suggest ABA may modulate bone remodelling in PsA and help preserve joint structure alongside clinical improvements." 
Journal • Immunology • Inflammatory Arthritis • Psoriasis • Psoriatic Arthritis • Rheumatology • Seronegative Spondyloarthropathies
http://www.ncbi.nlm.nih.gov/pubmed/42857349
 
Alp Temiz; Arnd Kleyer; Dagmar Werner; David Simon; Filippo Fagni; Frank Roemer; Georg Schett; Giulia Corte; Jürgen Rech; Koray Tascilar; Louis Schuster; Melek Yalcin-Mutlu; Sara Bayat
 
Oct 11, 2026
 
Prev Next